Proteopedia:Featured SEL/1: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
<table> | <table> | ||
<tr><td>[[Image:Anim Avian Influenza Neuraminidase.gif]]</td></tr> | <tr><td>[[Image:Anim Avian Influenza Neuraminidase.gif]]</td></tr> | ||
<tr><td>'''Avian Influenza Neuraminidase'''< | <tr><td><div class='scrolling'>'''Avian Influenza Neuraminidase'''<br> | ||
''Eric Martz''<br> | |||
H5N1 bird flu has seemed a likely pandemic threat for decades, but the first new influenza virus to emerge as an imminent pandemic threat in the 21st century is H1N1 swine flu. The drug oseltamivir (Tamiflu®) inhibits flu neuraminidase, a component necessary for virus spread, in susceptible flu strains. Luckily H1N1 swine flu is susceptible (at least in early May, 2009). The development of oseltamivir was guided, in part, by crystallographically determined structures of flu neuraminidase. Neuraminidase is a homotetramer, shown with oseltamivir bound. Oseltamivir was designed to fit N2/N9 (neuraminidases from other strains of flu). Serendipitously, it also fits N1, doing so by pulling one side of the binding site against itself (induced fit). | H5N1 bird flu has seemed a likely pandemic threat for decades, but the first new influenza virus to emerge as an imminent pandemic threat in the 21st century is H1N1 swine flu. The drug oseltamivir (Tamiflu®) inhibits flu neuraminidase, a component necessary for virus spread, in susceptible flu strains. Luckily H1N1 swine flu is susceptible (at least in early May, 2009). The development of oseltamivir was guided, in part, by crystallographically determined structures of flu neuraminidase. Neuraminidase is a homotetramer, shown with oseltamivir bound. Oseltamivir was designed to fit N2/N9 (neuraminidases from other strains of flu). Serendipitously, it also fits N1, doing so by pulling one side of the binding site against itself (induced fit). | ||
</div> | </div> | ||
</td></tr> | </td></tr> | ||
</table> | </table> |